Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Kefir

What does the research say about Kefir?

2 health outcomes synthesised

Research on kefir has examined its potential effects on 2 health outcomes related to metabolic health. The strongest evidence area is for reducing HOMA-IR, an indicator of insulin resistance, supported by 3 studies at moderate evidence strength. Across these studies, kefir consumption typically lasted around 84 days, though dosing information was limited, with only one study specifying 180 mL per day.

Strongest evidence: The most supported outcome is reduced HOMA-IR, classified as moderate evidence strength. All 3 studies reported beneficial effects, with effect sizes ranging from small to large. Two meta-analyses found large reductions (WMD -2.56, 95% CI -3.82 to -1.30; MD -1.71), while one RCT showed a small reduction that was not superior to an unfermented milk control. Median study duration was 84 days, but dose data were limited (only one study reported 180 mL/day).

Mixed or weaker evidence: For reduced fasting blood glucose levels, the evidence strength is low. Of 3 meta-analyses, 2 reported moderate beneficial reductions of approximately 8–10 mg/dL (p < 0.01), but the largest (with 314 participants) found no significant effect, introducing uncertainty. No consistent dose or duration was reported across these studies.

Effective dose patterns: No cross-cutting dose insights emerged, as only one study across both outcomes specified a dose (180 mL/day for HOMA-IR). Most analyses did not report consistent dosing information, preventing identification of a typical effective range.

Population insights: No cross-cutting population patterns were available, as neither synthesis reported specific population subgroups (e.g., age, health status).

Notable caveats: Both evidence bases are small (only 3 studies each). The HOMA-IR evidence is subject to potential publication bias, as null-result studies are less likely to be published. Additionally, the HOMA-IR effect may not be specific to kefir — one RCT found improvement but not superior to an unfermented milk control. For fasting blood glucose, the largest meta-analysis found no effect, creating conflicting findings.

Frequently asked

  • What is kefir good for according to research?
    Research on kefir has focused on two metabolic health outcomes: reducing HOMA-IR (an insulin resistance marker) and reducing fasting blood glucose. The strongest evidence is for HOMA-IR, where all 3 studies reported beneficial effects, though the evidence base is small and subject to publication bias.
  • What dose of kefir is typically used in studies?
    Dose reporting was inconsistent across studies. Only one study for HOMA-IR specified a dose of 180 mL per day. No consistent dose or duration was reported for the fasting blood glucose studies, so no typical effective dose can be identified from the current evidence.
  • Who benefits most from kefir?
    The research syntheses did not report specific population subgroups (e.g., age, baseline health status). Therefore, no conclusions can be drawn about which populations benefit most from kefir based on this evidence.
  • Are there caveats or limitations in the research on kefir?
    Yes. Both outcomes are based on only 3 studies each, making conclusions preliminary. The HOMA-IR evidence may be affected by publication bias, and one study found that kefir's effect was not superior to unfermented milk, suggesting the benefit may not be unique to kefir. For fasting blood glucose, the largest meta-analysis found no effect, creating conflicting results.
  • Does kefir help with reducing HOMA-IR?
    All 3 studies reported beneficial effects on HOMA-IR, with effect sizes ranging from small to large. Two meta-analyses found large reductions, while one RCT found only a small reduction that was not significantly better than unfermented milk. The evidence strength is moderate, meaning the findings are fairly consistent but still preliminary.
  • Does kefir help with reducing fasting blood glucose?
    Two of 3 meta-analyses found moderate reductions of approximately 8–10 mg/dL. However, the largest meta-analysis (314 participants) found no significant effect, so the evidence is mixed and classified as low strength. No reliable dose or duration recommendations can be made.

  • RAW Probiotics, Ultimate Care

    By Garden of Life

    4.6 (1.5K reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $41.99
    		In
    Vitacost
    $41.99
    		In
    Vitamin Shoppe
    $48.99
    		In
Back to top